Organon’s $954 Million Acquisition of Forendo Pharma

Krogerus and Wilmer Cutler Pickering Hale and Dorr advised Forendo Pharma on the deal. Organon, a global healthcare company formed through a spin-off from Merck, is…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now